EndorTech

Synthetic Beta‑Endorphin Aerosol Platform for Pain Relief

Health Tech & Life Sciences
Active
Pre-Funding Tel Aviv-Yafo Founded 2023
Total raised
Stage
Pre-Funding
Founded
2023
Headcount
1
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

EndorTech delivers commercial quantities of synthetic biological beta Endorphin, as a natural alternative to the current opioid Pain killers , with no side effects and at a very worthwhile price, rendering the old methods obsolete.

EndorTech developed a patented disruptive revolutionize mechanism using pure synthetic aerosoled beta Endorphin, which is a smart protein brain food (neuropeptide -delivering messages between neurons by a specific sequence of amino acids) produced in tiny quantities and quickly drain the reservoir.

The company's cutting-edge aerosol technology allows you to inhale endorphins, providing rapid pain relief by directly targeting the source of discomfort. This innovative delivery system ensures quick and effective pain relief without the need for pills or injections.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalspain-reliefdrug-delivery